A rare case of cardiovascular toxicity caused by pembrolizumab leading to coronary vasospasm

31 August 2024 (11:03 - 11:16)
Organised by: Logo
Congress Presentation Part of: Cardio-oncology (2) Clinical ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

ESC 365 is supported by

ESC 365 is supported by